Filgotinib may be associated with a lower risk of herpes zoster compared with other Janus kinase inhibitors in rheumatoid arthritis.

HSV type 1 reactivation was prevalent among critically ill patients with COVID-19 and was independently associated with ...

64 percent of people under 50 have HSV-1 – WHO’s report breaks down herpes symptoms, prevention, treatment, and why stigma is ...

A Bengaluru gynaecologist says she is seeing more women in their late teens and early twenties with genital infections, prompting her to share an important message on safe sex.

TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI” or the “Company”), a Health IT company leveraging its artificial intelligence platform EinsteinRx ™ and ...

New research suggests the two-dose Shingrix vaccine could also lower the risk of dementia, adding to its benefits for adults ...

IGNYTE showed that patients with confirmed progression on an anti-PD-1-based regimen who received RP1 plus nivolumab had a 34% response rate, with a median duration of 24.8 months, and 15% of them ...

Herpetic infection signals differ across targeted therapies for patients with AD, including for overall and type-specific herpetic infections.

Japan: In an exploratory randomized trial from Japan, patients with rheumatoid arthritis who started the JAK inhibitor ...

A randomized trial in patients with rheumatoid arthritis (RA) suggests that the timing of when a Janus kinase (JAK) inhibitor ...

A Bengaluru gynaecologist has warned about a growing number of young women visiting clinics with genital infections.

ABL Diagnostics (Euronext Paris – Compartiment B – ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions for infectious diseases, announces the commercial availability of ...